Pharyngeal Carcinoma — Trials

Pharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 191
Ph III recruiting: 58
Growth YoY: +6.7%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (85)

clinicaltrialsPublishedShowing 151–180 of 180 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06752382	Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC	not yet recruiting	Phase 2	58	Zhejiang Cancer HospitalOTHER	1	Dec 30, 2024	clinicaltrials
NCT06733948	ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients	recruiting	Phase 2	50	National University Hospital, SingaporeOTHER	1	Dec 13, 2024	clinicaltrials